+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients



Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients



Transplantation Proceedings 33(7-8): 3161-3163




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045645898

Download citation: RISBibTeXText

PMID: 11750357

DOI: 10.1016/s0041-1345(01)02346-6


Related references

Conversion from cyclosporine to tacrolimus in pediatric renal transplant recipients with chronic rejection. Nephrology Dialysis Transplantation 17(Abstracts Suppl. 1): 177, 2002

Conversion from cyclosporine to tacrolimus following successful treatment of acute rejection minimizes risk of recurrent rejection in renal transplant recipients. Journal of Urology 157(4 SUPPL ): 431, 1997

Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Transplantation Proceedings 28(4): 2107-2108, 1996

Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. Transplantation Proceedings 32(7): 1714-1715, 2000

Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrology, Dialysis, Transplantation 21(2): 510-517, 2006

Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. Transplantation Proceedings 33(1-2): 1034-1035, 2001

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients. European Journal of Clinical Pharmacology 65(5): 473-481, 2009

Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. Transplantation 77(4): 532-537, 2004

Conversion of immunosuppression with cyclosporine to tacrolimus due to steroid-resistive acute rejection or chronic kidney graft rejection. Kidney & Blood Pressure Research 22(4-6): 351-352, 1999

Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients. Transplantation 75(12): 2058-2063, 2003

Reversal of steroid resistant rejection with ok 3 in azathioprine and cyclosporine treated renal allograft recipients. Journal of Cellular Biochemistry Suppl. (10 PART A): 105, 1986

Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience. Transplantation Proceedings 33(7-8): 3590-3591, 2001

International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. Journal of Thoracic and Cardiovascular Surgery 127(4): 1126-1132, 2004

Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report. Transplantation Proceedings 30(4): 1245-1246, 1998

Comparative study of tacrolimus and cyclosporine for prevention of acute rejection in renal transplant recipients. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 691A, Sept, 1998